1. Michael R. Kraus, MD, PhD Associate Professor of Medicine Department of Gastroenterology and Hepatology Medizinische Klinik II Kreiskliniken Altötting – Burghausen…

1.Extrahepatic Manifestations of Hepatitis C Virus Infection Service de Médecine Interne, et CNRS UMR 7087Université Pierre et Marie Curie Centre National de Référence…

1. Drug Prices in the US: How High Can They Go?- Issues and Discussion1October 2014 2. A talk on rising drug prices --- Why might you be interested?22As a patient• You…

RESEARCH ARTICLE Evaluation of Canonical siRNA and Dicer Substrate RNA for Inhibition of Hepatitis C Virus Genome Replication – A Comparative Study Bruno Carneiro1,2*,…

1. Marc Bourlière, MD Graham R. Foster, FRCP, PhD Managing Cirrhotic HCV Patients: Whom to Treat, How to Treat This program is supported by an educational grant from 2.…

Slide 1HCV response to treatment in IDUs (PWID) in the Czech Republic Vratislav Rehak Remedis Clinic, Prague, Czech Republic 1 Institute of Public Health “Dr. Milan Jovanovic…

Slide 1 HCV Telehealth Training Program Challenges and benefits of integrating hepatitis C care into a primary care setting Takako Schaninger, MD Program Director Southern…

Slide 1 Management of HIV infection in HIV/HCV co-infected patients Mark Hull, MD, MHSc, FRCPC Division of AIDS University of British Columbia Slide 2 Objectives Review the…

Slide 1 The Future: Is Ribavirin Still Useful? David Nelson, MD Professor of Medicine, Microbiology, and Molecular Genetics Associate Dean, Clinical Research and Training…

Slide 1 PRIMARY CARE HEPATITIS C TREATMENT OUTCOMES USING PROJECT ECHO MODEL CHRIS BOYLE 3/26/2013 Hepatitis C Slide 2 Outline Discuss Chronic Hepatitis C Describe Project…